Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 6 (2006), Pages 1164-1176
http://dx.doi.org/10.1100/tsw.2006.220
Mini-Review Article

Fmr1 KO Mice as a Possible Model of Autistic Features

Laboratoire de Neurosciences Cognitives, CNRS UMR 5106, Université de Bordeaux I, Bat B2 - Avenue des Facultés, 33405 Talence Cedex, France

Received 26 June 2006; Revised 1 September 2006; Accepted 6 September 2006

Academic Editor: Michael Posner

Copyright © 2006 Maude Bernardet and Wim E. Crusio.

Citations to this Article [83 citations]

The following is the list of published articles that have cited the current article.

  • Gül Dölen, Emily Osterweil, B.S. Shankaranarayana Rao, Gordon B. Smith, Benjamin D. Auerbach, Sumantra Chattarji, and Mark F. Bear, “Correction of Fragile X Syndrome in Mice,” Neuron, vol. 56, no. 6, pp. 955–962, 2007. View at Publisher · View at Google Scholar
  • Cheney J. G. Drew, Rachel J. Kyd, and A. Jennifer Morton, “Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal,” Human Molecular Genetics, vol. 16, no. 19, pp. 2288–2305, 2007. View at Publisher · View at Google Scholar
  • Cyrille Vaillend, Roseline Poirier, and Serge Laroche, “Genes, plasticity and mental retardation,” Behavioural Brain Research, vol. 192, no. 1, pp. 88–105, 2008. View at Publisher · View at Google Scholar
  • Jessica Molina, Paulina Carmona-Mora, Jacqueline Chrast, Paola M. Krall, Cesar P. Canales, James R. Lupski, Alexandre Reymond, and Katherina Walz, “Abnormal social behaviors and altered gene expression rates in a mouse model for Potocki-Lupski syndrome,” Human Molecular Genetics, vol. 17, no. 16, pp. 2486–2495, 2008. View at Publisher · View at Google Scholar
  • Edward S. Brodkin, “Social behavior phenotypes in Fragile X syndrome, autism, and the Fmr1 knockout mouse: Theoretical comment on McNaughton et al. (2008),” Behavioral Neuroscience, vol. 122, no. 2, pp. 483–489, 2008. View at Publisher · View at Google Scholar
  • Caitlyn H. McNaughton, Jisook Moon, Myla S. Strawderman, Kenneth N. Maclean, Jeffrey Evans, and Barbara J. Strupp, “Evidence for social anxiety and impaired social cognition in a mouse model of Fragile X syndrome,” Behavioral Neuroscience, vol. 122, no. 2, pp. 293–300, 2008. View at Publisher · View at Google Scholar
  • Gul Dolen, and Mark F. Bear, “Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome,” Journal Of Physiology-London, vol. 586, no. 6, pp. 1503–1508, 2008. View at Publisher · View at Google Scholar
  • Daniel J. Kelley, Anita Bhattacharyya, Garet P. Lahvis, Jerry C. P. Yin, Jim Malter, and Richard J. Davidson, “The cyclic AMP phenotype of fragile X and autism,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 8, pp. 1533–1543, 2008. View at Publisher · View at Google Scholar
  • R. Jansen, K. Linkenkaer-Hansen, T. Heistek, J. Timmerman, Huibert D. Mansvelder, Arjen B. Brussaard, M. de Gunst, and A. van Ooyen, “Inbred mouse strains differ in multiple hippocampal activity traits,” European Journal of Neuroscience, vol. 30, no. 6, pp. 1092–1100, 2009. View at Publisher · View at Google Scholar
  • Lisa R. Merlin, “The Fragile X Mental Retardation Protein: A Valuable Partner In The Battle Against Epileptogenesis,” Epilepsy Currents, vol. 9, no. 4, pp. 116–118, 2009. View at Publisher · View at Google Scholar
  • Darci M. Nielsen, Jeffrey J. Evans, William J. Derber, Kenzie A. Johnston, Mark L. Laudenslager, Linda S. Crnic, and Kenneth N. Maclean, “Mouse Model of Fragile X Syndrome: Behavioral and Hormonal Response to Stressors,” Behavioral Neuroscience, vol. 123, no. 3, pp. 677–686, 2009. View at Publisher · View at Google Scholar
  • Gül Dölen, and Mark F. Bear, “Fragile x syndrome and autism: from disease model to therapeutic targets,” Journal of Neurodevelopmental Disorders, vol. 1, no. 2, pp. 133–140, 2009. View at Publisher · View at Google Scholar
  • Wenzhong William Min, Christopher J. Yuskaitis, Qijiang Yan, Christopher Sikorski, Shengqiang Chen, Richard S. Jope, and Robert P. Bauchwitz, “Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential,” Neuropharmacology, vol. 56, no. 2, pp. 463–472, 2009. View at Publisher · View at Google Scholar
  • Julie B. Zang, Elena D. Nosyreva, Corinne M. Spencer, Lenora J. Volk, Kiran Musunuru, Ru Zhong, Elizabeth F. Stone, Lisa A. Yuva-Paylor, Kimberly M. Huber, Richard Paylor, Jennifer C. Darnell, and Robert B. Darnell, “A Mouse Model of the Human Fragile X Syndrome I304N Mutation,” Plos Genetics, vol. 5, no. 12, 2009. View at Publisher · View at Google Scholar
  • Gul Dolen, Randall L. Carpenter, Timothy D. Ocain, and Mark F. Bear, “Mechanism-based approaches to treating fragile X,” Pharmacology & Therapeutics, vol. 127, no. 1, pp. 78–93, 2010. View at Publisher · View at Google Scholar
  • K. B. Baker, S. P. Wray, R. Ritter, S. Mason, T. H. Lanthorn, and K.V. Savelieva, “Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments,” Genes, Brain and Behavior, pp. no–no, 2010. View at Publisher · View at Google Scholar
  • Marjelo A. Mines, Christopher J. Yuskaitis, Margaret K. King, Eleonore Beurel, and Richard S. Jope, “GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism,” Plos One, vol. 5, no. 3, 2010. View at Publisher · View at Google Scholar
  • Regina Dahlhaus, and Alaa El-Husseini, “Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome,” Behavioural Brain Research, vol. 208, no. 1, pp. 96–105, 2010. View at Publisher · View at Google Scholar
  • Christopher J. Yuskaitis, Marjelo A. Mines, Margaret K. King, J. David Sweatt, Courtney A. Miller, and Richard S. Jope, “Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome,” Biochemical Pharmacology, vol. 79, no. 4, pp. 632–646, 2010. View at Publisher · View at Google Scholar
  • E. Carla Parker-Athill, and Jun Tan, “Maternal Immune Activation and Autism Spectrum Disorder: Interleukin-6 Signaling as a Key Mechanistic Pathway,” Neurosignals, vol. 18, no. 2, pp. 113–128, 2010. View at Publisher · View at Google Scholar
  • Christina Gross, Elizabeth M Berry-Kravis, and Gary J Bassell, “Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond,” Neuropsychopharmacology, vol. 37, no. 1, pp. 178–195, 2011. View at Publisher · View at Google Scholar
  • Zhong-Hua Liu, De-Maw Chuang, and Carolyn Beebe Smith, “Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome,” International Journal Of Neuropsychopharmacology, vol. 14, no. 5, pp. 618–630, 2011. View at Publisher · View at Google Scholar
  • Paul H. Patterson, “Modeling Autistic Features in Animals,” Pediatric Research, vol. 69, no. 5Part2, pp. 34R–40R, 2011. View at Publisher · View at Google Scholar
  • Susanna Pietropaolo, Aurelie Guilleminot, Benoit Martin, Francesca R. D'Amato, and Wim E. Crusio, “Genetic-Background Modulation of Core and Variable Autistic-Like Symptoms in Fmr1 Knock-Out Mice,” Plos One, vol. 6, no. 2, 2011. View at Publisher · View at Google Scholar
  • Corinne M. Spencer, Olga Alekseyenko, Shannon M. Hamilton, Alexia M. Thomas, Ekaterina Serysheva, Lisa A. Yuva-Paylor, and Richard Paylor, “Modifying Behavioral Phenotypes in Fmr1KO Mice: Genetic Background Differences Reveal Autistic-Like Responses,” Autism Research, vol. 4, no. 1, pp. 40–56, 2011. View at Publisher · View at Google Scholar
  • Elodie Ey, Claire S. Leblond, and Thomas Bourgeron, “Behavioral Profiles of Mouse Models for Autism Spectrum Disorders,” Autism Research, vol. 4, no. 1, pp. 5–16, 2011. View at Publisher · View at Google Scholar
  • Shengqiang Chen, Xuegang Luo, Quan Yang, Weiwen Sun, Kaiyi Cao, Xi Chen, Yueling Huang, Lijun Dai, and Yonghong Yi, “Lithium chloride ameliorates learning and memory ability and inhibits glycogen synthase kinase-3 beta activity in a mouse model of fragile X syndrome,” Neural Regeneration Research, vol. 6, no. 31, pp. 2452–2459, 2011. View at Publisher · View at Google Scholar
  • Joshua J. Meidenbauer, John G. Mantis, and Thomas N. Seyfried, “The EL mouse: A natural model of autism and epilepsy,” Epilepsia, pp. no–no, 2011. View at Publisher · View at Google Scholar
  • Dejan B. Budimirovic, and Walter E. Kaufmann, “What Can We Learn about Autism from Studying Fragile X Syndrome?,” Developmental Neuroscience, vol. 33, no. 5, pp. 379–394, 2011. View at Publisher · View at Google Scholar
  • Garet P. Lahvis, and Lois M. Black, “Social interactions in the clinic and the cage: Toward a more valid mouse model of autism,” Neuromethods, vol. 50, pp. 153–192, 2011. View at Publisher · View at Google Scholar
  • Marjelo A. Mines, and Richard S. Jope, “Glycogen synthase kinase-3: a promising therapeutic target for fragile X syndrome,” Frontiers In Molecular Neuroscience, vol. 4, 2011. View at Publisher · View at Google Scholar
  • Sheng-Qiang Chen, Xue-Gang Luo, Quan Yang, Kai-Yi Cao, Wei-Wen Sun, Yue-Ling Huang, Yan-Song Shen, and Li-Jun Dai, “Therapeutic effects of lithium chloride on the elevated plus-maze behavior in FMR1 knockout mice,” Acta Anatomica Sinica, vol. 43, no. 3, pp. 328–334, 2012. View at Publisher · View at Google Scholar
  • Hongen Wei, Carl Dobkin, Ashfaq M. Sheikh, Mazhar Malik, W. Ted Brown, and Xiaohong Li, “The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome,” Plos One, vol. 7, no. 5, 2012. View at Publisher · View at Google Scholar
  • M. Uutela, J. Lindholm, V. Louhivuori, H. Wei, L. M. Louhivuori, A. Pertovaara, K. Åkerman, E. Castrén, and M. L. Castrén, “ Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits ,” Genes, Brain and Behavior, vol. 11, no. 5, pp. 513–523, 2012. View at Publisher · View at Google Scholar
  • Sarah E. Rotschafer, Michael S. Trujillo, Lorraine E. Dansie, Iryna M. Ethell, and Khaleel A. Razak, “Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome,” Brain Research, vol. 1439, pp. 7–14, 2012. View at Publisher · View at Google Scholar
  • E. Ey, M. Yang, A. M. Katz, L. Woldeyohannes, J. L. Silverman, C. S. Leblond, P. Faure, N. Torquet, A.-M. Le Sourd, T. Bourgeron, and J. N. Crawley, “Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4,” Genes, Brain and Behavior, 2012. View at Publisher · View at Google Scholar
  • Zhao-hui Xu, Qi Yang, Lan Ma, Shui-bing Liu, Guang-sheng Chen, Yu-mei Wu, Xiao-qiang Li, Gang Liu, and Ming-gao Zhao, “Deficits in LTP Induction by 5-HT2A Receptor Antagonist in a Mouse Model for Fragile X Syndrome,” Plos One, vol. 7, no. 10, 2012. View at Publisher · View at Google Scholar
  • Giovanni Provenzano, Giulia Zunino, Sacha Genovesi, Paola Sgado, and Yuri Bozzi, “Mutant mouse models of autism spectrum disorders,” Disease Markers, vol. 33, no. 5, pp. 225–239, 2012. View at Publisher · View at Google Scholar
  • Shenfeng Qiu, Kimberly A. Aldinger, and Pat Levitt, “Modeling of Autism Genetic Variations in Mice: Focusing on Synaptic and Microcircuit Dysfunctions,” Developmental Neuroscience, vol. 34, no. 2-3, pp. 88–100, 2012. View at Publisher · View at Google Scholar
  • Aubin Michalon, Andreas Bruns, Céline Risterucci, Michael Honer, Theresa M. Ballard, Laurence Ozmen, Georg Jaeschke, Joseph G. Wettstein, Markus von Kienlin, Basil Künnecke, and Lothar Lindemann, “Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice,” Biological Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Hyejung Won, Won Mah, and Eunjoon Kim, “Autism spectrum disorder causes, mechanisms, and treatments: Focus on neuronal synapses,” Frontiers in Molecular Neuroscience, no. JULY, 2013. View at Publisher · View at Google Scholar
  • Richard Delorme, Elodie Ey, Roberto Toro, Marion Leboyer, Christopher Gillberg, and Thomas Bourgeron, “Progress toward treatments for synaptic defects in autism,” Nature Medicine, vol. 19, no. 6, pp. 685–694, 2013. View at Publisher · View at Google Scholar
  • Sarah Rotschafer, and Khaleel Razak, “Altered auditory processing in a mouse model of fragile X syndrome,” Brain Research, vol. 1506, pp. 12–24, 2013. View at Publisher · View at Google Scholar
  • Brandy N. Routh, Daniel Johnston, and Darrin H. Brager, “Loss of Functional A-Type Potassium Channels in the Dendrites of CA1 Pyramidal Neurons from a Mouse Model of Fragile X Syndrome,” Journal of Neuroscience, vol. 33, no. 50, pp. 19442–19450, 2013. View at Publisher · View at Google Scholar
  • D. Oddi, W.E. Crusio, F.R. D’Amato, and S. Pietropaolo, “Monogenic mouse models of social dysfunction: Implications for autism,” Behavioural Brain Research, 2013. View at Publisher · View at Google Scholar
  • Marco Pignatelli, Marco Feligioni, Sonia Piccinin, Gemma Molinaro, Ferdinando Nicoletti, and Robert Nisticò, “Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders,” Current Pharmaceutical Design, vol. 19, no. 36, pp. 6480–6490, 2013. View at Publisher · View at Google Scholar
  • Bharathi S. Gadad, Laura Hewitson, Keith A. Young, and Dwight C. German, “Neuropathology and Animal Models of Autism: Genetic and Environmental Factors,” Autism Research and Treatment, vol. 2013, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Tiffany D. Rogers, Eric Mckimm, Price E. Dickson, Dan Goldowitz, Charles D. Blaha, and Guy Mittleman, “Is autism a disease of the cerebellum?: An integration of clinical and pre-clinical research,” Frontiers in Systems Neuroscience, no. 2013, 2013. View at Publisher · View at Google Scholar
  • Lucia Ciranna, and Maria Vincenza Catania, “5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Rafaelle Rossignol, Isabelle Ranchon-Cole, Arnaud Paris, Ameziane Herzine, Astrid Perche, David Laurenceau, Pauline Bertrand, Christine Cercy, Jacques Pichon, Stephane Mortaud, Sylvain Briault, Arnaud Menuet, and Olivier Perche, “Visual Sensorial Impairments in Neurodevelopmental Disorders: Evidence for a Retinal Phenotype in Fragile X Syndrome,” Plos One, vol. 9, no. 8, 2014. View at Publisher · View at Google Scholar
  • Susanna Pietropaolo, Mina G. Goubran, Corinne Joffre, Audrey Aubert, Valerie Lemaire-Mayo, Wim E. Crusio, and Sophie Layé, “Dietary Supplementation Of Omega-3 Fatty Acids Rescues Fragile X Phenotypes In Fmr1-Ko Mice,” Psychoneuroendocrinology, 2014. View at Publisher · View at Google Scholar
  • Marko Uutela, Jesse Lindholm, Tomi Rantamäki, Juzoh Umemori, Kerri Hunter, Vootele Võikar, and Maija L. Castrén, “Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Adam Michael Stewart, Michael Nguyen, Keith Wong, Manoj K. Poudel, and Allan V. Kalueff, “Developing zebrafish models of autism spectrum disorder (ASD),” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 27–36, 2014. View at Publisher · View at Google Scholar
  • Lily Kim, Lucy He, Hans Maaswinkel, Liqun Zhu, Howard Sirotkin, and Wei Weng, “Anxiety, hyperactivity and stereotypy in a zebrafish model of fragile X syndrome and autism spectrum disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Sarah E. Rotschafer, “Auditory processing in fragile X syndrome,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Diego Oddi, Enejda Subashi, Silvia Middei, Luigi Bellocchio, Valerie Lemaire-Mayo, Manuel Guzmán, Wim E Crusio, Francesca R D'Amato, and Susanna Pietropaolo, “Early Social Enrichment Rescues Adult Behavioral and Brain Abnormalities in a Mouse Model of Fragile X Syndrome,” Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • S.M. Francis, A. Sagar, T. Levin-Decanini, W. Liu, C.S. Carter, and S. Jacob, “Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • I. L. Kovalenko, and N. N. Kudryavtseva, “Alteration of Social Behaviors in Male Mice of CBA/Lac Strain under Agonistic Interactions,” Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I P Pavlova, vol. 65, no. 4, pp. 486–497, 2015. View at Publisher · View at Google Scholar
  • Christina Gross, Anne Hoffmann, Gary J. Bassell, and Elizabeth M. Berry-Kravis, “Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back,” Neurotherapeutics, 2015. View at Publisher · View at Google Scholar
  • Lara Costa, Lara M. Sardone, Enza Lacivita, Marcello Leopoldo, and Lucia Ciranna, “Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome,” Frontiers in Behavioral Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Emilie M. Sørensen, Freja Bertelsen, Pia Weikop, Maria M. Skovborg, Tue Banke, Kim R. Drasbek, and Jørgen Scheel-Krüger, “Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse,” Behavioural Pharmacology, vol. 26, pp. 733–740, 2015. View at Publisher · View at Google Scholar
  • Maria Sundberg, and Mustafa Sahin, “Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex,” Journal Of Child Neurology, vol. 30, no. 14, pp. 1954–1962, 2015. View at Publisher · View at Google Scholar
  • Ki Chan Kim, Jeehae Rhee, Jong-Eun Park, Dong-Keun Lee, Chang Soon Choi, Ji-Woon Kim, Han-Woong Lee, Mi-Ryoung Song, Hee Jeong Yoo, ChiHye Chung, and Chan Young Shin, “Overexpression of Telomerase Reverse Transcriptase Induces Autism-like Excitatory Phenotypes in Mice,” Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  • de Esch Cef, W.E. van den Berg, Buijsen Ram, I.A. Jaafar, I.M. Nieuwenhuizen-Bakker, F. Gasparini, S.A. Kushner, and R. Willemsen, “Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test,” Neurobiology of Disease, 2015. View at Publisher · View at Google Scholar
  • D. Sinclair, B. Oranje, K.A. Razak, S.J. Siegel, and S. Schmid, “Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models,” Neuroscience & Biobehavioral Reviews, 2016. View at Publisher · View at Google Scholar
  • Atsushi Sato, “mTOR, a potential target to treat autism spectrum disorder,” CNS and Neurological Disorders - Drug Targets, vol. 15, no. 5, pp. 533–543, 2016. View at Publisher · View at Google Scholar
  • Ki Chan Kim, Edson Luck Gonzales, María T. Lázaro, Chang Soon Choi, Geon Ho Bahn, Hee Jeong Yoo, and Chan Young Shin, “Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders,” Biomolecules & Therapeutics, vol. 24, no. 3, pp. 207–243, 2016. View at Publisher · View at Google Scholar
  • Luis de la Torre-Ubieta, Hyejung Won, Jason L Stein, and Daniel H Geschwind, “Advancing the understanding of autism disease mechanisms through genetics,” Nature Medicine, vol. 22, no. 4, pp. 345–361, 2016. View at Publisher · View at Google Scholar
  • Rie Ohashi, Keizo Takao, Tsuyoshi Miyakawa, and Nobuyuki Shiina, “Comprehensive behavioral analysis of RNG105 (Caprin1) heterozygous mice: Reduced social interaction and attenuated response to novelty,” Scientific Reports, vol. 6, pp. 20775, 2016. View at Publisher · View at Google Scholar
  • I. L. Kovalenko, and N. N. Kudryavtseva, “Changes in the Social Behavior of Male CBA/Lac Mice in Response to Agonistic Interactions,” Neuroscience and Behavioral Physiology, 2016. View at Publisher · View at Google Scholar
  • Alicja Puścian, Szymon Łęski, Grzegorz Kasprowicz, Maciej Winiarski, Joanna Borowska, Tomasz Nikolaev, Paweł M Boguszewski, Hans-Peter Lipp, and Ewelina Knapska, “Eco-HAB as a fully automated and ecologically relevant assessment of social impairments in mouse models of autism,” eLife, vol. 5, 2016. View at Publisher · View at Google Scholar
  • Christopher M. McGraw, Christopher S. Ward, and Rodney C. Samaco, “Genetic rodent models of brain disorders: Perspectives on experimental approaches and therapeutic strategies,” American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 175, no. 3, pp. 368–379, 2017. View at Publisher · View at Google Scholar
  • James M. Ding, Richard Gray, Boris V. Zemelman, Daniel Johnston, Jennifer J. Siegel, Raymond A. Chitwood, Clayton Payne, and William Taylor, “Prefrontal cortex dysfunction in Fragile X mice depends on the continued absence of Fragile X mental retardation protein in the adult brain,” Journal of Neuroscience, vol. 37, no. 31, pp. 7305–7317, 2017. View at Publisher · View at Google Scholar
  • Luigi Mazzone, Giulia Giovagnoli, Martina Siracusano, Valentina Postorino, and Paolo Curatolo, “Drug treatments for core symptoms of autism spectrum disorder: Unmet needs and future directions,” Journal of Pediatric Neurology, vol. 15, no. 3, pp. 134–142, 2017. View at Publisher · View at Google Scholar
  • Julie Gaudissard, Melanie Ginger, Marika Premoli, Maurizio Memo, Andreas Frick, and Susanna Pietropaolo, “Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases,” Autism Research, 2017. View at Publisher · View at Google Scholar
  • Valerie Lemaire-Mayo, Enejda Subashi, Nadia Henkous, Daniel Beracochea, and Susanna Pietropaolo, “Behavioral effects of chronic stress in the Fmr1 mouse model for fragile X syndrome,” Behavioural Brain Research, vol. 320, pp. 128–135, 2017. View at Publisher · View at Google Scholar
  • Luis A. Martinez, and Maria Victoria Tejada-Simon, “Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Maria E. Sheean, Violeta Stoyanova-Beninska, Giuseppe Capovilla, Dinah Duarte, Matthias P. Hofer, Michel Hoffmann, Armado Magrelli, Segundo Mariz, Stelios Tsigkos, Evyenia Shaili, Benedetta Polsinelli, Mario Ricciardi, Milton Bonelli, Pavel Balabanov, Kristina Larsson, and Bruno Sepodes, “Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions,” Drug Discovery Today, 2017. View at Publisher · View at Google Scholar
  • Cynthia X. He, Daniel A. Cantu, Shilpa S. Mantri, William A. Zeiger, Carlos Portera-Cailliau, and Anubhuti Goel, “Tactile defensiveness and impaired adaptation of neuronal activity in the Fmr1 knock-out mouse model of autism,” Journal of Neuroscience, vol. 37, no. 27, pp. 6475–6487, 2017. View at Publisher · View at Google Scholar
  • Jiangfei Chen, Lei Lei, Linjie Tian, Fei Hou, Courtney Roper, Xiaoqing Ge, Yuxin Zhao, Yuanhong Chen, Qiaoxiang Dong, Robert L. Tanguay, and Changjiang Huang, “Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism,” Neurotoxicology and Teratology, vol. 66, pp. 8–16, 2018. View at Publisher · View at Google Scholar
  • Jonathan W. Lovelace, Iryna M. Ethell, Devin K. Binder, and Khaleel A. Razak, “Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome,” Neurobiology of Disease, 2018. View at Publisher · View at Google Scholar
  • Regina Dahlhaus, “Of Men and Mice: Modeling the Fragile X Syndrome,” Frontiers in Molecular Neuroscience, vol. 11, 2018. View at Publisher · View at Google Scholar
  • X. Shawn Liu, Hao Wu, Marine Krzisch, Xuebing Wu, John Graef, Julien Muffat, Denes Hnisz, Charles H. Li, Bingbing Yuan, Chuanyun Xu, Yun Li, Dan Vershkov, Angela Cacace, Richard A. Young, and Rudolf Jaenisch, “Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene,” Cell, vol. 172, no. 5, pp. 979–992.e6, 2018. View at Publisher · View at Google Scholar